Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Banner MD Anderson Cancer Center, Gilbert, Arizona City of Hope, Duarte, California City of Hope Orange County, Lennar, Irvine, California University of California, Los Angeles (UCLA), Los Angeles, California Moffitt Cancer Center, Tampa, Florida City of Hope Chicago, Zion, Illinois Massachusetts General Hospital Cancer Center, Boston, Massachusetts Profound Research, Farmington Hills, Michigan Ohio State University, Columbus, Ohio Oncology Consultants, Houston, Texas South Texas Accelerated Research Therapeutics, San Antonio, Texas